Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 28 articles: HTML format Text format

Single Articles

December 2018
1. YUAN C, Tao X, Zheng D, Pan Y, et al
   The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
   J Surg Oncol. 2018 Dec 9. doi: 10.1002/jso.25308.
   PubMed     Text format     Abstract available
   
   
   
2. KADEER X, Wang L, Zhang L, Shi W, et al
   Modified hook-wire placement technique for localizing multiple pulmonary nodules.
   J Surg Oncol. 2018;118:1188-1193.
   PubMed     Text format     Abstract available
   
   
   November 2018
3. VITI A, Socci L, Congregado M, Ismail M, et al
   The everlasting issue of prolonged air leaks after lobectomy for non-small cell lung cancer: A data-driven prevention planning model in the era of minimally invasive approaches.
   J Surg Oncol. 2018 Nov 6. doi: 10.1002/jso.25289.
   PubMed     Text format     Abstract available
   
   
   October 2018
4. KUMAR NAN, Verma K, Shinde RS, Kammar P, et al
   Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes.
   J Surg Oncol. 2018 Oct 17. doi: 10.1002/jso.25273.
   PubMed     Text format     Abstract available
   
   
   September 2018
5. GILL RR, Murphy DJ, Kravets S, Sholl LM, et al
   Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.
   J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25241.
   PubMed     Text format     Abstract available
   
   
   
6. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
   The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
   J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25251.
   PubMed     Text format     Abstract available
   
   
   
7. QUERO-VALENZUELA F, Piedra-Fernandez I, Hernandez-Escobar F
   Readmission after pulmonary resection for lung cancer.
   J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25207.
   PubMed     Text format    
   
   
   August 2018
8. NEWTON AD, Predina JD, Nie S, Low PS, et al
   Intraoperative fluorescence imaging in thoracic surgery.
   J Surg Oncol. 2018;118:344-355.
   PubMed     Text format     Abstract available
   
   
   June 2018
9. IMANISHI N, Hirai A, Yoneda K, Shimajiri S, et al
   Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung.
   J Surg Oncol. 2018;117:1563-1569.
   PubMed     Text format     Abstract available
   
   
   
10. STILES ZE, Dickson PV, Glazer ES, Murphy AJ, et al
    Desmoplastic small round cell tumor: A nationwide study of a rare sarcoma.
    J Surg Oncol. 2018;117:1759-1767.
    PubMed     Text format     Abstract available
    
    
    May 2018
11. SAMBRI A, Bianchi G, Cevolani L, Donati D, et al
    Can radical margins improve prognosis in primary and localized epithelioid sarcoma of the extremities?
    J Surg Oncol. 2018;117:1204-1210.
    PubMed     Text format     Abstract available
    
    
    April 2018
12. MIYAMOTO E, Chen-Yoshikawa TF, Ueshima C, Yoshizawa A, et al
    Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.
    J Surg Oncol. 2018 Apr 17. doi: 10.1002/jso.25045.
    PubMed     Text format     Abstract available
    
    
    
13. KAAKI S, Kidane B, Srinathan S, Tan L, et al
    Is tissue still the issue? Lobectomy for suspicious lung nodules without confirmation of malignancy.
    J Surg Oncol. 2018;117:977-984.
    PubMed     Text format     Abstract available
    
    
    March 2018
14. COLLAUD S, Provost B, Besse B, Fabre D, et al
    Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
    J Surg Oncol. 2018 Mar 24. doi: 10.1002/jso.25042.
    PubMed     Text format     Abstract available
    
    
    
15. SON BY, Cho S, Yum SW, Kim K, et al
    The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm.
    J Surg Oncol. 2018;117:451-456.
    PubMed     Text format     Abstract available
    
    
    
16. FISHER SB, Rafeeq S, Hess K, Grotz TE, et al
    Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).
    J Surg Oncol. 2018;117:685-691.
    PubMed     Text format     Abstract available
    
    
    February 2018
17. YU WS, Lee CY, Park SY, Suh JW, et al
    Prognostic factors for resected non-small cell lung cancer in patients with type 2 diabetes mellitus.
    J Surg Oncol. 2018 Feb 6. doi: 10.1002/jso.24989.
    PubMed     Text format     Abstract available
    
    
    
18. VODICKA J, Mukensnabl P, Vejvodova S, Spidlen V, et al
    A more sensitive detection of micrometastases of NSCLC in lymph nodes using the one-step nucleic acid amplification (OSNA) method.
    J Surg Oncol. 2018;117:163-170.
    PubMed     Text format     Abstract available
    
    
    January 2018
19. QUERO-VALENZUELA F, Piedra-Fernandez I, Martinez-Ceres M, Romero-Palacios PJ, et al
    Predictors for 30-day readmission after pulmonary resection for lung cancer.
    J Surg Oncol. 2018 Jan 22. doi: 10.1002/jso.24973.
    PubMed     Text format     Abstract available
    
    
    December 2017
20. SMITHY JW, Rosen JE, Gao SJ, Kim AW, et al
    Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.
    J Surg Oncol. 2017;116:1193-1196.
    PubMed     Text format     Abstract available
    
    
    November 2017
21. KAPETANAKIS EI, Sidiropoulou T, Koumarianou A, Kostopanagiotou K, et al
    Delivering quality lung cancer care in crisis-wracked Greece.
    J Surg Oncol. 2017 Nov 22. doi: 10.1002/jso.24874.
    PubMed     Text format    
    
    
    
22. SHE Y, Zhao L, Dai C, Ren Y, et al
    Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: A multi-institutional study.
    J Surg Oncol. 2017;116:756-762.
    PubMed     Text format     Abstract available
    
    
    October 2017
23. APRILE V, Bertoglio P, Dini P, Palmiero G, et al
    Is left upper lobectomy always worthwhile for early stage lung cancer? A comparison between left upper lobectomy, trisegmentectomy, and lingulectomy.
    J Surg Oncol. 2017 Oct 19. doi: 10.1002/jso.24884.
    PubMed     Text format     Abstract available
    
    
    September 2017
24. MARULLI G, Rendina EA, Klepetko W, Perkmann R, et al
    Surgery for T4 lung cancer invading the thoracic aorta: Do we push the limits?
    J Surg Oncol. 2017 Sep 18. doi: 10.1002/jso.24784.
    PubMed     Text format     Abstract available
    
    
    August 2017
25. WASEDA R, Klikovits T, Hoda MA, Hoetzenecker K, et al
    Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.
    J Surg Oncol. 2017;116:227-235.
    PubMed     Text format     Abstract available
    
    
    June 2017
26. TAIOLI E, Liu B, Nicastri DG, Lieberman-Cribbin W, et al
    Personal and hospital factors associated with limited surgical resection for lung cancer, in-hospital mortality and complications in New York State.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24697.
    PubMed     Text format     Abstract available
    
    
    May 2017
27. YANG X, Sun F, Chen L, Shi M, et al
    Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.
    J Surg Oncol. 2017 May 22. doi: 10.1002/jso.24677.
    PubMed     Text format     Abstract available
    
    
    April 2017
28. MCINTYRE A, Ganti AK
    Lung cancer-A global perspective.
    J Surg Oncol. 2017 Apr 18. doi: 10.1002/jso.24532.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: